Kothari Petrochemicals Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: October 8, 2025, 8:27 pm

Competitors of Kothari Petrochemicals Ltd

All Competitor Stocks of Kothari Petrochemicals Ltd

Quarterly Result

Last Updated: August 20, 2025, 8:00 am

Below is a detailed analysis of the quarterly data for Kothari Petrochemicals Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 161.00 Cr.. The value appears strong and on an upward trend. It has increased from 153.00 Cr. (Mar 2025) to 161.00 Cr., marking an increase of 8.00 Cr..
• For Expenses, as of Jun 2025, the value is 138.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 130.00 Cr. (Mar 2025) to 138.00 Cr., marking an increase of 8.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 23.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 23.00 Cr..
• For OPM %, as of Jun 2025, the value is 14.00%. The value appears to be declining and may need further review. It has decreased from 15.00% (Mar 2025) to 14.00%, marking a decrease of 1.00%.
• For Other Income, as of Jun 2025, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 2.00 Cr..
• For Interest, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
• For Depreciation, as of Jun 2025, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 2.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 23.00 Cr.. The value appears strong and on an upward trend. It has increased from 22.00 Cr. (Mar 2025) to 23.00 Cr., marking an increase of 1.00 Cr..
• For Tax %, as of Jun 2025, the value is 23.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 23.00%.
• For Net Profit, as of Jun 2025, the value is 18.00 Cr.. The value appears strong and on an upward trend. It has increased from 17.00 Cr. (Mar 2025) to 18.00 Cr., marking an increase of 1.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 2.99. The value appears strong and on an upward trend. It has increased from 2.94 (Mar 2025) to 2.99, marking an increase of 0.05.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: July 22, 2025, 3:30 pm

Growth

Last Updated: September 5, 2025, 9:20 am

Balance Sheet

Last Updated: October 10, 2025, 2:24 pm

Below is a detailed analysis of the balance sheet data for Kothari Petrochemicals Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 59.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 59.00 Cr..
• For Reserves, as of Mar 2025, the value is 247.00 Cr.. The value appears strong and on an upward trend. It has increased from 187.00 Cr. (Mar 2024) to 247.00 Cr., marking an increase of 60.00 Cr..
• For Borrowings, as of Mar 2025, the value is 3.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 0.00 Cr. (Mar 2024) to 3.00 Cr., marking an increase of 3.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 69.00 Cr.. The value appears to be improving (decreasing). It has decreased from 72.00 Cr. (Mar 2024) to 69.00 Cr., marking a decrease of 3.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 378.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 319.00 Cr. (Mar 2024) to 378.00 Cr., marking an increase of 59.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 211.00 Cr.. The value appears strong and on an upward trend. It has increased from 130.00 Cr. (Mar 2024) to 211.00 Cr., marking an increase of 81.00 Cr..
• For CWIP, as of Mar 2025, the value is 2.00 Cr.. The value appears strong and on an upward trend. It has increased from 1.00 Cr. (Mar 2024) to 2.00 Cr., marking an increase of 1.00 Cr..
• For Investments, as of Mar 2025, the value is 40.00 Cr.. The value appears to be declining and may need further review. It has decreased from 74.00 Cr. (Mar 2024) to 40.00 Cr., marking a decrease of 34.00 Cr..
• For Other Assets, as of Mar 2025, the value is 126.00 Cr.. The value appears strong and on an upward trend. It has increased from 114.00 Cr. (Mar 2024) to 126.00 Cr., marking an increase of 12.00 Cr..
• For Total Assets, as of Mar 2025, the value is 378.00 Cr.. The value appears strong and on an upward trend. It has increased from 319.00 Cr. (Mar 2024) to 378.00 Cr., marking an increase of 59.00 Cr..

Notably, the Reserves (247.00 Cr.) exceed the Borrowings (3.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Kothari Petrochemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 16, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 15) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 16, the value is 1.62. This value is below the healthy minimum of 5. It has decreased from 2.03 (Mar 15) to 1.62, marking a decrease of 0.41.
• For Diluted EPS (Rs.), as of Mar 16, the value is 1.62. This value is below the healthy minimum of 5. It has decreased from 2.03 (Mar 15) to 1.62, marking a decrease of 0.41.
• For Cash EPS (Rs.), as of Mar 16, the value is 2.07. This value is below the healthy minimum of 3. It has decreased from 2.45 (Mar 15) to 2.07, marking a decrease of 0.38.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 16, the value is 11.53. It has increased from 11.04 (Mar 15) to 11.53, marking an increase of 0.49.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 16, the value is 11.53. It has increased from 11.04 (Mar 15) to 11.53, marking an increase of 0.49.
• For Revenue From Operations / Share (Rs.), as of Mar 16, the value is 36.20. It has decreased from 47.34 (Mar 15) to 36.20, marking a decrease of 11.14.
• For PBDIT / Share (Rs.), as of Mar 16, the value is 3.13. This value is within the healthy range. It has decreased from 3.72 (Mar 15) to 3.13, marking a decrease of 0.59.
• For PBIT / Share (Rs.), as of Mar 16, the value is 2.67. This value is within the healthy range. It has decreased from 3.29 (Mar 15) to 2.67, marking a decrease of 0.62.
• For PBT / Share (Rs.), as of Mar 16, the value is 2.47. This value is within the healthy range. It has decreased from 2.87 (Mar 15) to 2.47, marking a decrease of 0.40.
• For Net Profit / Share (Rs.), as of Mar 16, the value is 1.61. This value is below the healthy minimum of 2. It has decreased from 2.02 (Mar 15) to 1.61, marking a decrease of 0.41.
• For NP After MI And SOA / Share (Rs.), as of Mar 16, the value is 1.61. This value is below the healthy minimum of 2. It has decreased from 2.02 (Mar 15) to 1.61, marking a decrease of 0.41.
• For PBDIT Margin (%), as of Mar 16, the value is 8.66. This value is below the healthy minimum of 10. It has increased from 7.85 (Mar 15) to 8.66, marking an increase of 0.81.
• For PBIT Margin (%), as of Mar 16, the value is 7.38. This value is below the healthy minimum of 10. It has increased from 6.95 (Mar 15) to 7.38, marking an increase of 0.43.
• For PBT Margin (%), as of Mar 16, the value is 6.81. This value is below the healthy minimum of 10. It has increased from 6.06 (Mar 15) to 6.81, marking an increase of 0.75.
• For Net Profit Margin (%), as of Mar 16, the value is 4.45. This value is below the healthy minimum of 5. It has increased from 4.25 (Mar 15) to 4.45, marking an increase of 0.20.
• For NP After MI And SOA Margin (%), as of Mar 16, the value is 4.45. This value is below the healthy minimum of 8. It has increased from 4.25 (Mar 15) to 4.45, marking an increase of 0.20.
• For Return on Networth / Equity (%), as of Mar 16, the value is 13.98. This value is below the healthy minimum of 15. It has decreased from 18.25 (Mar 15) to 13.98, marking a decrease of 4.27.
• For Return on Capital Employeed (%), as of Mar 16, the value is 21.57. This value is within the healthy range. It has decreased from 27.72 (Mar 15) to 21.57, marking a decrease of 6.15.
• For Return On Assets (%), as of Mar 16, the value is 8.53. This value is within the healthy range. It has decreased from 10.00 (Mar 15) to 8.53, marking a decrease of 1.47.
• For Long Term Debt / Equity (X), as of Mar 16, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 15) which recorded 0.00.
• For Total Debt / Equity (X), as of Mar 16, the value is 0.26. This value is within the healthy range. It has decreased from 0.34 (Mar 15) to 0.26, marking a decrease of 0.08.
• For Asset Turnover Ratio (%), as of Mar 16, the value is 1.86. It has decreased from 2.44 (Mar 15) to 1.86, marking a decrease of 0.58.
• For Current Ratio (X), as of Mar 16, the value is 1.48. This value is below the healthy minimum of 1.5. It has increased from 1.33 (Mar 15) to 1.48, marking an increase of 0.15.
• For Quick Ratio (X), as of Mar 16, the value is 1.24. This value is within the healthy range. It has increased from 1.13 (Mar 15) to 1.24, marking an increase of 0.11.
• For Inventory Turnover Ratio (X), as of Mar 16, the value is 15.96. This value exceeds the healthy maximum of 8. It has decreased from 27.09 (Mar 15) to 15.96, marking a decrease of 11.13.
• For Dividend Payout Ratio (NP) (%), as of Mar 16, the value is 61.67. This value exceeds the healthy maximum of 50. It has increased from 49.30 (Mar 15) to 61.67, marking an increase of 12.37.
• For Dividend Payout Ratio (CP) (%), as of Mar 16, the value is 47.92. This value is within the healthy range. It has increased from 40.64 (Mar 15) to 47.92, marking an increase of 7.28.
• For Earning Retention Ratio (%), as of Mar 16, the value is 38.33. This value is below the healthy minimum of 40. It has decreased from 50.70 (Mar 15) to 38.33, marking a decrease of 12.37.
• For Cash Earning Retention Ratio (%), as of Mar 16, the value is 52.08. This value is within the healthy range. It has decreased from 59.36 (Mar 15) to 52.08, marking a decrease of 7.28.
• For Interest Coverage Ratio (X), as of Mar 16, the value is 15.35. This value is within the healthy range. It has increased from 8.88 (Mar 15) to 15.35, marking an increase of 6.47.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 16, the value is 8.89. This value is within the healthy range. It has increased from 5.81 (Mar 15) to 8.89, marking an increase of 3.08.
• For Enterprise Value (Cr.), as of Mar 16, the value is 9.16. It has decreased from 22.27 (Mar 15) to 9.16, marking a decrease of 13.11.
• For EV / Net Operating Revenue (X), as of Mar 16, the value is 0.04. This value is below the healthy minimum of 1. It has decreased from 0.07 (Mar 15) to 0.04, marking a decrease of 0.03.
• For EV / EBITDA (X), as of Mar 16, the value is 0.49. This value is below the healthy minimum of 5. It has decreased from 1.01 (Mar 15) to 0.49, marking a decrease of 0.52.
• For MarketCap / Net Operating Revenue (X), as of Mar 16, the value is 0.04. This value is below the healthy minimum of 1. It has increased from 0.03 (Mar 15) to 0.04, marking an increase of 0.01.
• For Retention Ratios (%), as of Mar 16, the value is 38.32. This value is within the healthy range. It has decreased from 50.69 (Mar 15) to 38.32, marking a decrease of 12.37.
• For Price / BV (X), as of Mar 16, the value is 0.14. This value is below the healthy minimum of 1. It has decreased from 0.15 (Mar 15) to 0.14, marking a decrease of 0.01.
• For Price / Net Operating Revenue (X), as of Mar 16, the value is 0.04. This value is below the healthy minimum of 1. It has increased from 0.03 (Mar 15) to 0.04, marking an increase of 0.01.
• For EarningsYield, as of Mar 16, the value is 0.94. This value is below the healthy minimum of 5. It has decreased from 1.19 (Mar 15) to 0.94, marking a decrease of 0.25.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness